ABSTRACT
Minimal değişiklik hastalığı(MDH)
. Solid tumors are often associated with immunocomplex-mediated glomerulonephritis, such as membranous nephropathy (10) . Thymoma, renal cell carcinoma, mesothelioma, lung, colon, bladder, liver, breast, pancreas, duodenum, prostate cancers rarely have also been shown to be associated with MCD(6-11). Some of the MCDrelated infections are syphilis, tuberculosis, mycoplasma, hepatitis C, echinococcal infection, borreliosis (Lyme disease)(6,8,12).Human immunodeficiency virus (HIV) infection is often associated with collapsing type focal segmental glomerulosclerosis, but its association with MCD has been previously described (13) .Approximately 30% of all MDH cases have an allergy history(3,14). MCD may show moderate mesangial depolarization suggesting the presence of mesangial IgA and IgA nephropathy(13,15).MDH-related renal or glomerular diseases include systemic lupus erythematosus, type 1 diabetes mellitus, polycystic kidney disease, and HIV nephropathy(6,16).Other diseases associated with MCD are chronic graft versus host disease, sclerosing cholangitis, sarcoidosis, Graves' disease, thyroiditis, vasculitis, myasthenia gravis, Guillain Barré syndrome, dermatitis herpetiformis, primary balloon cholangitis, and antiphospholipid syndrome and underlying mechanism is unknown(6,17).Ekstasy (3,4 methylenedioxy-N-methylamphetamine, MDMA) is a psychoactive substance having the formula C11H15NO2 (18) . MCD frequently refers to nephrotic syndrome findings (edema, hypoalbuminemia, proteinuria at nephrotic level (3.5 gr / 24 h)).Renal function is often preserved in MCD, unless there are tables such as concomitant acute tubular necrosis, tubulointerstitial nephritis, and undiagnosed FSGS.Treatment is started with steroids and steroids respond very well, especially in children.Cyclophosphamide treatment is often given in relapses and steroid-dependent cases, and cyclosporine treatment may be given in cases of relapses despite 2 cycles of cyclophosphamide treatment.We aimed to emphasize that the use of ecstasy should be kept in mind because of the atypical clinical course accompanied by toxic hepatitis during the follow-up of patients presenting with nephrotic syndrome.
CASE REPORT
A 25-year-old male patient was admitted to the hospital with a complaint of swelling in his body, which has increased over the past week..The general condition of the patient was good, conscious open, full orientation and cooperative.The patient's body temperature was 380C, pulse rate was 88 beats / min, blood pressure was 135/75 mmHg. Anasarca, edema was detected on physical examination. The laboratory values on the patient's admission, at the follow-up in the clinic and on the discharge are presented on the table 1.
The laboratory values on the patient's admission, low density lipoprotein(LDL) was 335 mg/dl, albümin was 1,6 g/dl, alanin aminotransferase (ALT) was 67 U/L, aspart aminotransferase(AST) was 65 U/L, blood ure nitrogen and creatinin were normal and proteinuria at 24h was 8,6 g/day.
Viral hepatitis serologic markers were negative in the patient who had a history of ecstasy during the last 2 months. Abdominal ultrasonography revealed normal renal and liver size and parenchyma echogenicity. Serologic studies have shown that C3 (complex 3), C4 (complex 4), anti nuclear antibody (ANA), Anti-neutrophil cytoplasmic antibodies (ANCAs), IgG (immunoglobulin G), IgA (immunoglobulin A), IgM (immunoglobulin M), protein electrophoresis, kappa and lambda values and immunoelectrophoresis were normal. Kidney biopsy was performed in a patient with a nephrotic syndrome clinic and accompanying toxic hepatitis.Biopsy results were reported consistent with minimal change disease.1 mg / kg / day oral methylprednisolone therapy was started.During the clinical follow-up, fluid restriction and diuretic therapy did not provide adequate diuresis and a total of 4 sessions of hemodialysis were performed on deterioration in renal function tests.Liver and kidney function tests returned to normal, diuresis increased and the patient who was not required to have hemodialysis was discharged and control visit recommended. At the 6th week of follow-up, a complete remission was achieved and steroid therapy was cut off.Finally, the patient who came to the our clinic 1 month ago is on full remission.
DISCUSSION
Ecstasy is a psychostimulated substance that is increasingly used in the last period.The use of ecstasy has negative effects on many organs, especially the kidneys, liver and heart.The effects of ecstasy use include malignant hypertension, tachycardia, hyperthermia, acute renal failure, hypotonic hyponatremia, rhabdomyolysis, hepatotoxicity and neurological findings such as agitation, anxiety(19-25).In our patient with isolated nephrotic syndrome clinic, glomerular pathologies such as minimal change syndrome, primary focal segmantal glomerulosclerosis, amylodosis, membranous nephropathy were considered. Because of the lack of a chronic disease story, secondary amyloidosis was not considered and so kidney biopsy was performed in the patient just to make a clinically clear distinction.The biopsy result was reported as minimal change disease because no light microscopic finding of any pathological findings, no immune depositing in the immunofluorescence microscopy was detected. Electron microscopy could not be done due to technical reasons and and the fusion of burrows with typical electron microscopic findings could not be shown.
It is thought that ecstasy may cause atypical clinical syndrome which is not seen frequently in MCD, such as the need for hemodialysis during the follow-up and the development of hepatotoxicity.Hepatic enzyme elevation was assessed as toxic hepatitis due to spontaneous 
